VIPpharma ApS: Financial statements 2024
CVR: 38744763
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,138,702 and a net result of DKK 1,191,483 compared with DKK 743,463 the year before. That is an increase of 21.4% compared with the year before. Equity in the 2024 report amounted to DKK 1,838,543. The solvency ratio was 66.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,138,702
- Profit/Loss
- DKK 1,191,483
- Equity
- DKK 1,838,543
- Total Assets
- DKK 2,780,175
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.1 mio. | 1.2 mio. | 1.8 mio. | 2 |
| 2023 | - | 2.6 mio. | 743 t. | 1.7 mio. | 2 |
| 2022 | - | 2.4 mio. | 634 t. | 2 mio. | 2 |
| 2021 | - | 2.1 mio. | 428 t. | 2.4 mio. | 2 |
| 2020 | - | 2.2 mio. | 716 t. | 3.7 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
VIPpharma ApS has published its annual report for 2023. Gross profit came to DKK 2,584,996, and the net result was DKK 743,463.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.